| 2024-04-10 12:35 | CC:BCT | Briacell Therapeutics Corp (2) | 3.88 | News Release200 | Briacell releases cancer immunotherapy preclinical data |
| 2024-04-09 12:28 | CC:BCT | Briacell Therapeutics Corp (2) | 3.95 | News Release200 | Briacell to present Bria-IMT posters at AACR meeting |
| 2024-03-18 17:14 | CC:BCT | Briacell Therapeutics Corp (2) | 3.91 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-03-18 17:07 | CC:BCT | Briacell Therapeutics Corp (2) | 3.91 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-03-07 11:43 | CC:BCT | Briacell Therapeutics Corp (2) | 4.24 | News Release200 | Briacell signs LOI for Bria-OTS+, Bria-PROS+ work |
| 2024-02-27 08:43 | CC:BCT | Briacell Therapeutics Corp (2) | 4.48 | News Release200 | Briacell files complaints on "illegal trading activity" |
| 2024-02-07 12:31 | CC:BCT | Briacell Therapeutics Corp (2) | 5.28 | News Release200 | Briacell sees 61% cancer control rate in Bria-IMT study |
| 2024-02-06 12:54 | CC:BCT | Briacell Therapeutics Corp (2) | 5.26 | News Release200 | Briacell begins GMP manufacturing of Bria-Pros+ |
| 2024-01-30 23:35 | CC:BCT | Briacell Therapeutics Corp (2) | 5.80 | News Release200 | Briacell shareholders approve all resolutions at AGM |
| 2024-01-22 17:02 | CC:BCT | Briacell Therapeutics Corp (2) | | SEDAR Final Short Form Prospectus810 | SEDAR Final Short Form Prospectus |
| 2024-01-22 14:35 | CC:BCT | Briacell Therapeutics Corp (2) | 5.66 | SEDAR Preliminary Short Form Prospectus819 | SEDAR Preliminary Short Form Prospectus |
| 2024-01-04 11:36 | CC:BCT | Briacell Therapeutics Corp (2) | 6.69 | News Release200 | Briacell brags of Bria-IMT eye-bulging patient results |
| 2023-12-28 10:45 | CC:BCT | Briacell Therapeutics Corp (2) | 7.25 | News Release200 | Briacell talks Bria-IMT response rate in breast cancer |
| 2023-12-20 12:02 | CC:BCT | Briacell Therapeutics Corp (2) | 5.46 | News Release200 | Briacell releases Bria-IMT preliminary survival data |
| 2023-12-14 15:13 | CC:BCT | Briacell Therapeutics Corp (2) | 5.69 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-12-14 15:13 | CC:BCT | Briacell Therapeutics Corp (2) | 5.69 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-12-06 13:00 | CC:BCT | Briacell Therapeutics Corp (2) | 7.13 | News Release200 | Briacell to present 3 posters on Bria-IMT study results |
| 2023-12-06 12:43 | CC:BCT | Briacell Therapeutics Corp (2) | 7.13 | News Release200 | Briacell talks Bria-IMT survival, clinical benefit data |
| 2023-11-30 10:14 | CC:BCT | Briacell Therapeutics Corp (2) | 7.12 | News Release200 | Briacell talks responder improvement in Bria-IMT study |
| 2023-11-03 10:34 | CC:BCT | Briacell Therapeutics Corp (2) | 5.95 | News Release200 | Briacell receives FDA OK to proceed with Bria-OTS study |
| 2023-10-25 17:30 | CC:BCT | Briacell Therapeutics Corp (2) | 6.74 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2023-10-25 17:28 | CC:BCT | Briacell Therapeutics Corp (2) | 6.74 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-10-25 17:22 | CC:BCT | Briacell Therapeutics Corp (2) | 6.74 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-10-25 12:55 | CC:BCT | Briacell Therapeutics Corp (2) | 6.78 | News Release200 | Briacell Therapeutics forms medical advisory board |
| 2023-10-04 11:10 | CC:BCT | Briacell Therapeutics Corp (2) | 7.96 | News Release200 | Briacell partners with NYCBS for phase 3 Bria-IMT study |
| 2023-10-03 11:06 | CC:BCT | Briacell Therapeutics Corp (2) | 8.23 | News Release200 | Briacell Therapeutics begins phase 3 Bria-IMT study |
| 2023-09-08 09:10 | CC:BCT | Briacell Therapeutics Corp (2) | 8.88 | News Release200 | Briacell completes enrolment in phase 2 Bria-IMT study |
| 2023-09-07 14:12 | CC:BCT | Briacell Therapeutics Corp (2) | 9.10 | SEDAR Early Warning Report807 | SEDAR Early Warning Report |
| 2023-08-31 13:32 | CC:BCT | Briacell Therapeutics Corp (2) | 9.58 | News Release200 | Briacell Therapeutics closes BriaPro spinout |
| 2023-08-31 09:35 | CC:BCT | Briacell Therapeutics Corp (2) | 9.70 | News Release200 | Briacell accepts LOI for Bria-IMT phase 2 trial |
| 2023-08-25 15:11 | CC:BCT | Briacell Therapeutics Corp (2) | 10.00 | News Release200 | Briacell receives court OK for BriaPro spinout |
| 2023-08-18 12:32 | CC:BCT | Briacell Therapeutics Corp (2) | 9.75 | News Release200 | Briacell Therapeutics shareholders approve spinout |
| 2023-08-16 10:41 | CC:BCT | Briacell Therapeutics Corp (2) | 9.42 | News Release200 | Briacell wins NCI grant for Bria-OTS immunotherapies |
| 2023-06-27 11:13 | CC:BCT | Briacell Therapeutics Corp (2) | 8.50 | News Release200 | Briacell receives OK for Bria-IMT breast cancer study |
| 2023-06-14 17:50 | CC:BCT | Briacell Therapeutics Corp (2) | 7.65 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-06-14 17:49 | CC:BCT | Briacell Therapeutics Corp (2) | 7.65 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-25 09:19 | CC:BCT | Briacell Therapeutics Corp (2) | 8.19 | News Release200 | Briacell to spin out preclinical assets to BriaPro |
| 2023-05-19 11:49 | CC:BCT | Briacell Therapeutics Corp (2) | 7.92 | News Release200 | Briacell closes $4-million (U.S.) investment by Prevail |
| 2023-05-15 11:01 | CC:BCT | Briacell Therapeutics Corp (2) | 8.85 | News Release200 | Briacell signs CRO agreement with Prevail InfoWorks |